| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |